Rare diseases
Investigational molecules
Locations
Uppsalalaan 15, 3584 CT Utrecht, The Netherlands
Clinical research in malignant solid tumors with a focus on anti-cancer antibody development and early evaluation of therapeutic activity in oncology.
Work in this area centers on establishing the safety and tolerability profile of a novel therapeutic antibody for solid tumor indications.
Genmab B.V. runs clinical trials in conditions such as Neoplasm malignant, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
SpainIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
